Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tirzepatide (Mounjaro/Zepbound) offers dual GLP-1 and GIP agonism, achieving approximately 20.9% weight loss
Y.et al (2019)
Notably, up to 47% of T2D patients and 36% of non-T2D patients restarted their medication within the same timeframe
We adjust your protocol as your body changes
This data should be interpreted alongside clinical assessment, labs, and your treatment goals to guide the most personalized pathway forward
Stream Philadelphia News for free, 24/7, wherever you are with NBC10
US$ 24.34
US$ 22.97
US$ 26.65
US$ 23.28
US$ 26.87
US$ 22.84
US$ 25.49
US$ 21.00
US$ 20.73
